Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fasciola hepatica | 26 | 2023 | 33 | 11.300 |
Why?
|
| Helminth Proteins | 13 | 2021 | 25 | 6.590 |
Why?
|
| Fascioliasis | 17 | 2020 | 18 | 4.620 |
Why?
|
| Fatty Acid-Binding Proteins | 6 | 2021 | 22 | 3.710 |
Why?
|
| Antigens, Helminth | 12 | 2018 | 34 | 3.570 |
Why?
|
| Antibodies, Helminth | 13 | 2018 | 23 | 3.030 |
Why?
|
| Macrophages | 6 | 2023 | 439 | 2.230 |
Why?
|
| Cytokines | 8 | 2023 | 602 | 2.050 |
Why?
|
| Saposins | 8 | 2018 | 10 | 1.950 |
Why?
|
| Lipopolysaccharides | 4 | 2023 | 220 | 1.780 |
Why?
|
| Shock, Septic | 3 | 2019 | 20 | 1.450 |
Why?
|
| Immunoglobulin G | 7 | 2024 | 237 | 1.420 |
Why?
|
| Antibodies, Neutralizing | 4 | 2024 | 109 | 1.320 |
Why?
|
| Glutathione Transferase | 3 | 2019 | 88 | 1.320 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2023 | 62 | 1.300 |
Why?
|
| Antibodies, Viral | 4 | 2024 | 262 | 1.110 |
Why?
|
| Vaccination | 7 | 2024 | 288 | 1.090 |
Why?
|
| Animals | 28 | 2023 | 15081 | 1.020 |
Why?
|
| Macrophages, Peritoneal | 2 | 2023 | 23 | 0.890 |
Why?
|
| Sepsis | 1 | 2023 | 80 | 0.860 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2018 | 448 | 0.800 |
Why?
|
| Mice | 14 | 2023 | 5913 | 0.790 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 24 | 0.790 |
Why?
|
| Mice, Inbred BALB C | 8 | 2021 | 661 | 0.770 |
Why?
|
| Dendritic Cells | 1 | 2021 | 113 | 0.760 |
Why?
|
| Monocytes | 2 | 2020 | 257 | 0.750 |
Why?
|
| Rabbits | 8 | 2018 | 283 | 0.730 |
Why?
|
| Inclusion Bodies | 2 | 2018 | 33 | 0.700 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 51 | 0.700 |
Why?
|
| Vaccines, Synthetic | 3 | 2010 | 72 | 0.680 |
Why?
|
| Schistosoma mansoni | 2 | 2011 | 18 | 0.670 |
Why?
|
| Protein Engineering | 1 | 2018 | 44 | 0.630 |
Why?
|
| Humans | 26 | 2024 | 37093 | 0.580 |
Why?
|
| Serologic Tests | 6 | 2022 | 43 | 0.560 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 121 | 0.560 |
Why?
|
| NF-kappa B | 1 | 2019 | 339 | 0.540 |
Why?
|
| RNA, Messenger | 4 | 2024 | 1207 | 0.540 |
Why?
|
| Cell Movement | 1 | 2018 | 571 | 0.510 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 81 | 0.500 |
Why?
|
| Macrophage Activation | 1 | 2014 | 56 | 0.480 |
Why?
|
| Parasitology | 1 | 2013 | 2 | 0.470 |
Why?
|
| Proteomics | 2 | 2020 | 325 | 0.470 |
Why?
|
| Escherichia coli | 4 | 2023 | 453 | 0.470 |
Why?
|
| Apoptosis | 1 | 2021 | 1398 | 0.470 |
Why?
|
| Recombinant Proteins | 5 | 2018 | 515 | 0.460 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 562 | 0.460 |
Why?
|
| Female | 14 | 2024 | 20969 | 0.430 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2012 | 47 | 0.420 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 26 | 0.390 |
Why?
|
| Ferritins | 1 | 2011 | 55 | 0.390 |
Why?
|
| Tremor | 1 | 2011 | 9 | 0.390 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 24 | 0.390 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 1371 | 0.380 |
Why?
|
| Placenta | 2 | 2022 | 97 | 0.380 |
Why?
|
| Movement | 1 | 2011 | 97 | 0.370 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 136 | 0.360 |
Why?
|
| Signal Transduction | 1 | 2019 | 1908 | 0.360 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 286 | 0.350 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 626 | 0.350 |
Why?
|
| Proteome | 1 | 2011 | 144 | 0.350 |
Why?
|
| Puerto Rico | 3 | 2023 | 1378 | 0.330 |
Why?
|
| DNA, Complementary | 4 | 2011 | 191 | 0.320 |
Why?
|
| Epitope Mapping | 2 | 2016 | 31 | 0.320 |
Why?
|
| Isoelectric Focusing | 2 | 2020 | 15 | 0.310 |
Why?
|
| Iron | 2 | 2024 | 225 | 0.300 |
Why?
|
| Cloning, Molecular | 3 | 2017 | 325 | 0.290 |
Why?
|
| Spleen | 3 | 2018 | 199 | 0.290 |
Why?
|
| Glycoproteins | 2 | 2004 | 106 | 0.280 |
Why?
|
| Epitopes | 1 | 2007 | 148 | 0.280 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2006 | 12 | 0.280 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1015 | 0.280 |
Why?
|
| Mice, Knockout | 2 | 2021 | 933 | 0.260 |
Why?
|
| Vaccines, DNA | 1 | 2005 | 23 | 0.260 |
Why?
|
| Chromatography, Affinity | 2 | 2018 | 67 | 0.260 |
Why?
|
| Blotting, Western | 4 | 2016 | 859 | 0.250 |
Why?
|
| Flow Cytometry | 2 | 2021 | 399 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 1609 | 0.250 |
Why?
|
| Amino Acid Sequence | 4 | 2011 | 1180 | 0.250 |
Why?
|
| Phytic Acid | 1 | 2024 | 4 | 0.240 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2015 | 115 | 0.240 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2023 | 39 | 0.230 |
Why?
|
| Diabetic Retinopathy | 1 | 2024 | 68 | 0.220 |
Why?
|
| Cells, Cultured | 2 | 2018 | 1518 | 0.210 |
Why?
|
| Dietary Supplements | 1 | 2024 | 208 | 0.210 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 234 | 0.210 |
Why?
|
| Neutralization Tests | 1 | 2021 | 53 | 0.200 |
Why?
|
| Disease Progression | 1 | 2024 | 601 | 0.200 |
Why?
|
| Cross Reactions | 3 | 2016 | 83 | 0.200 |
Why?
|
| Molecular Weight | 2 | 2012 | 167 | 0.200 |
Why?
|
| Molecular Sequence Data | 3 | 2011 | 1568 | 0.180 |
Why?
|
| Pregnancy | 2 | 2022 | 1549 | 0.180 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2020 | 25 | 0.180 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 277 | 0.180 |
Why?
|
| Gene Expression | 2 | 2017 | 674 | 0.170 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 336 | 0.170 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 62 | 0.170 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 974 | 0.160 |
Why?
|
| Cell-Free System | 1 | 2018 | 15 | 0.160 |
Why?
|
| Cytosol | 1 | 2018 | 93 | 0.160 |
Why?
|
| Antibody Formation | 1 | 2018 | 74 | 0.160 |
Why?
|
| Cell Survival | 1 | 2021 | 864 | 0.160 |
Why?
|
| Protein Binding | 1 | 2021 | 972 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2018 | 127 | 0.150 |
Why?
|
| Parasite Egg Count | 2 | 2009 | 4 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 421 | 0.150 |
Why?
|
| Sequence Alignment | 2 | 2011 | 265 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 211 | 0.150 |
Why?
|
| DNA, Helminth | 2 | 2010 | 6 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 70 | 0.150 |
Why?
|
| Mutation | 1 | 2021 | 1095 | 0.140 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2016 | 1 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 643 | 0.140 |
Why?
|
| Brain | 1 | 2024 | 1346 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 295 | 0.140 |
Why?
|
| Immunoglobulin E | 2 | 2007 | 55 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 1 | 2017 | 408 | 0.140 |
Why?
|
| Cell Line | 1 | 2020 | 1354 | 0.130 |
Why?
|
| Antigens, Protozoan | 1 | 2016 | 72 | 0.130 |
Why?
|
| Inflammation | 2 | 2023 | 618 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 70 | 0.130 |
Why?
|
| Chagas Disease | 1 | 2016 | 98 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 356 | 0.130 |
Why?
|
| Male | 5 | 2024 | 20025 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 107 | 0.130 |
Why?
|
| Adult | 3 | 2024 | 11712 | 0.130 |
Why?
|
| Survival Rate | 1 | 2015 | 311 | 0.120 |
Why?
|
| Chromatography, Gel | 1 | 2014 | 50 | 0.120 |
Why?
|
| Immune Evasion | 1 | 2014 | 16 | 0.120 |
Why?
|
| Trypanosoma cruzi | 1 | 2016 | 149 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 93 | 0.120 |
Why?
|
| Liver | 2 | 2009 | 479 | 0.120 |
Why?
|
| Integumentary System | 1 | 2013 | 1 | 0.120 |
Why?
|
| Models, Molecular | 1 | 2017 | 808 | 0.110 |
Why?
|
| Aged | 2 | 2024 | 6741 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 61 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 218 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 252 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2014 | 435 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2016 | 484 | 0.100 |
Why?
|
| Immunologic Tests | 1 | 2011 | 11 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2014 | 316 | 0.100 |
Why?
|
| Gene Library | 1 | 2012 | 57 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2015 | 928 | 0.100 |
Why?
|
| Isoelectric Point | 1 | 2011 | 9 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 183 | 0.100 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 78 | 0.100 |
Why?
|
| Middle Aged | 2 | 2024 | 10129 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 103 | 0.090 |
Why?
|
| DNA, Recombinant | 1 | 2010 | 17 | 0.090 |
Why?
|
| Injections, Intramuscular | 1 | 2010 | 20 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2013 | 384 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 33 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 173 | 0.090 |
Why?
|
| Cattle | 1 | 2011 | 477 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 893 | 0.090 |
Why?
|
| DNA Primers | 1 | 2009 | 286 | 0.080 |
Why?
|
| Plasmids | 1 | 2010 | 246 | 0.080 |
Why?
|
| Phylogeny | 1 | 2011 | 644 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 623 | 0.080 |
Why?
|
| Schistosomiasis mansoni | 1 | 2006 | 8 | 0.070 |
Why?
|
| Peptide Library | 1 | 2006 | 25 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 935 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 236 | 0.070 |
Why?
|
| Bile | 1 | 2004 | 10 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2004 | 108 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 357 | 0.060 |
Why?
|
| Feces | 1 | 2004 | 111 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2024 | 224 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2024 | 286 | 0.060 |
Why?
|
| Sphingolipid Activator Proteins | 1 | 2003 | 1 | 0.060 |
Why?
|
| Proteolipids | 1 | 2003 | 3 | 0.060 |
Why?
|
| RNA, Helminth | 1 | 2003 | 4 | 0.060 |
Why?
|
| Vagina | 1 | 2023 | 81 | 0.060 |
Why?
|
| Peptides | 1 | 2006 | 320 | 0.060 |
Why?
|
| Immune Sera | 1 | 2003 | 59 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2003 | 150 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 171 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 268 | 0.050 |
Why?
|
| Pulmonary Surfactants | 1 | 2003 | 26 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 269 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 550 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2003 | 111 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 25 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 72 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 103 | 0.040 |
Why?
|
| Hookworm Infections | 1 | 2016 | 1 | 0.040 |
Why?
|
| Schistosomiasis japonica | 1 | 2016 | 1 | 0.040 |
Why?
|
| Toxocariasis | 1 | 2016 | 2 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 189 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 82 | 0.030 |
Why?
|
| Multigene Family | 1 | 2016 | 106 | 0.030 |
Why?
|
| Antibodies, Protozoan | 1 | 2016 | 79 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1130 | 0.030 |
Why?
|